Inactive Instrument

News MORPHOSYS Other OTC

Stocks

End-of-day quote Other OTC
- USD - Intraday chart for MORPHOSYS
14-09-15 MorphoSys AG : Receives Research Grant to Develop Novel Therapeutic Antibodies Targeting GPCRs GL
14-09-04 MorphoSys AG : to Present at Six Investor Conferences in September GL
14-08-20 MorphoSys AG : to Host Conference Call on License Agreement with Emergent to Co-Develop and Commercialize Prostate Cancer Drug Candidate MOR209/ES414 GL
14-08-19 MorphoSys AG : and Emergent BioSolutions Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414 GL
14-07-28 MorphoSys AG : Provides Update on the Company's Proprietary Drug Portfolio GL
14-07-28 MorphoSys AG : Reports Results for the First Six Months of 2014 GL
14-07-23 MorphoSys AG : and Galapagos Advance Joint Antibody Program in Inflammatory Diseases into Preclinical Development GL
14-07-21 MorphoSys AG : to Host Q2 2014 Conference Call on 28 July 2014 GL
14-07-18 MorphoSys AG : Receives Additional Patents on Novel Antibody Platform Ylanthia in the US and First Patent in China GL
14-06-12 MorphoSys AG : and Merck Serono Enter Strategic Immuno-Oncology Collaboration GL
14-06-02 MorphoSys AG : to Present at Four Investor Conferences in June GL
14-05-23 MorphoSys AG : Annual General Meeting of MorphoSys AG Approves All Proposals of the Company's Management GL
14-05-20 MorphoSys AG : MOR208 Program to Receive Orphan Drug Designation from FDA and EMA for the Treatment of CLL/SLL GL
14-05-06 MorphoSys AG : to Present at Two Upcoming Investor Conferences GL
14-04-29 MorphoSys AG : and Temple University Sign Therapeutic Antibody Discovery Partnership GL
14-04-29 MorphoSys AG : Reports Results for the First Quarter of 2014 GL
14-04-23 MorphoSys AG : to Host Q1 2014 Conference Call on 29 April 2014 GL
14-04-11 MorphoSys AG : Announcement of the Convening of the AGM in Munich/Germany on 23 May 2014 according to sec. 121 para. 4a AktG with the objective of Europe-wide distribution GL
14-03-31 MorphoSys AG : to Present at Two Upcoming Investor Conferences GL
14-03-03 MorphoSys AG : to Present at Four Upcoming Investor Conferences GL
14-03-03 MorphoSys AG : to Start Share Buy-Back Program GL
14-02-28 MorphoSys AG : Reports Results for Fiscal Year 2013 GL
14-02-20 MorphoSys AG : Invitation to Year End 2013 Conference Call of MorphoSys AG on 28 February 2014 GL
14-02-17 MorphoSys AG : Announces Clinical Milestone in Anti-Inflammatory Program GL
14-02-10 MorphoSys AG : to Present at Three Investor Conferences in February GL
No results match your criteria